DCF — GENESIS MEDICAL CENTER - DAVENPORT
Enterprise Value: $-486.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-486.5M
Enterprise Value
$-157.3M
PV of Cash Flows
$-329.3M
PV of Terminal Value
$-530.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $403.6M | $-28.5M | -7.0% | $-45.6M | $-41.4M |
| Year 2 | $415.7M | $-25.2M | -6.0% | $-42.8M | $-35.4M |
| Year 3 | $428.2M | $-21.7M | -5.0% | $-39.8M | $-29.9M |
| Year 4 | $441.1M | $-20.1M | -5.0% | $-38.8M | $-26.5M |
| Year 5 | $454.3M | $-19.6M | -4.0% | $-38.8M | $-24.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-486.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$391.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07558598942252953
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5